Jessica Sido

Jessica Sido has worked in a variety of roles in the biomedical space since 2007. Jessica began their career as an Intern at the National Corn-to-Ethanol Research Center in 2007. In 2009, they became a Graduate Student at the University of South Carolina School of Medicine, where they conducted research on mouse models of transplant rejection, myeloid derived suppressor cell differentiation and induction due to cannabinoid treatments, and assessment of endocannabinoid level changes upon immune stimulation. Jessica also taught a second semester introductory biology lab. In 2015, they became a Research Fellow at the Dana-Farber Cancer Institute, where they were responsible for grant writing, bench science, mouse breeding, and manuscript preparation. Jessica also presented at the department level and served as the lab safety officer for their mentor's laboratory group. From 2018 to 2021, they worked at Kytopen as a Science Liaison Consultant, Senior Scientist, and Scientist. In their role as Science Liaison Consultant, they managed operations within the Kytopen laboratory and with external partners to ensure on time delivery of all necessary components and information. Jessica also documented, planned, organized, and tracked equipment, protocols, and experiments for Kytopen activities. Currently, Jessica works at Scilligence as a Customer Success Manager and at LabOlogy Consulting L.L.C. as a Consultant, where they specialize in the development of early stage and pivoting lab environments.

Jessica Sido began their educational career in 2002 when they obtained a Bachelor of Arts (B.A.) in Anthropology from Southern Illinois University Edwardsville. Jessica continued their studies at the same university and obtained a Bachelor of Science (B.S.) in Genetic Engineering Biology in 2006. In 2009, they obtained a Doctor of Philosophy (Ph.D.) in Biomedical Sciences- Pathology, Microbiology, Immunology from the University of South Carolina School of Medicine. Jessica then went on to become a Postdoctoral Fellow in Cancer Immunology at Harvard Medical School from 2015 to 2018.